Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostatic Neoplasms × AZD5305 × Clear all

Phase

Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 39 enzalutamide 25 Prednisone 21 Abiraterone Acetate 20 Magnetic Resonance Spectroscopy 17 bicalutamide 13 Radiotherapy 13 Cyclophosphamide 13 pembrolizumab 12 darolutamide 11 abiraterone 11 Leuprolide 11 Goserelin 11 Ipilimumab 10 apalutamide 9 Specimen Handling 9 Radiosurgery 9 Radiation 9 Biopsy 9 olaparib 8 Paclitaxel 8 Injections 8 Radiotherapy, Intensity-Modulated 7 Carboplatin 7 sargramostim 6 fludarabine 6 cabazitaxel 6 Pluvicto 6 Cisplatin 6 radium Ra 223 dichloride 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05938270 2026-02-24

ASCERTAIN

AstraZeneca

Phase 1 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡